@celestia's $TIA token is one of the few major crypto assets posting real growth this week, up roughly 47% over seven days while most of the market struggles. @injective's $INJ has also perfo
A
AnonymousCryptoCompass newsroom
October 17, 2026
2 min read
NEWS
CryptoCompass editorial visual for markets coverage.
@celestia's $TIA token is one of the few major crypto assets posting real growth this week, up roughly 47% over seven days while most of the market struggles. @injective's $INJ has also performed well, with a weekly gain of around 26%.
Only eight other tokens in the top 100 by market capitalisation are in the green over the week, including @Monero$XMR and @aeroxyz$AERO.
Celestia rally tied to Eden launch
Weekly gain figures for Celestia vary by data provider. FXStreet reported that TIA gained 57% on the week to reach $0.75, its highest level since November 2025. FXStreet linked the move to the launch of Eden, a new EVM-compatible chain for experimenting with AI agents. Eden relies on Celestia for data availability and uses TIA as its native token.
Not every analyst sees the rally as fully backed by usage. Crypto News Flash reported that TIA was up about 49% in a week, while the amount of data posted to Celestia fell by about 26% over a similar period and futures open interest rose sharply. It argued the market appears to be pricing in products that are still experimental.
Injective draws institutional interest
Injective's gain also differs slightly by source. FXStreet put INJ's weekly rise at 25%, while Coindoo cited CoinMarketCap data showing a seven-day gain of 29.65%, which ranked INJ sixth among the top 200 cryptocurrencies by market capitalisation.
FXStreet said the rise could be tied to institutional interest in the project. It noted that asset manager 21Shares filed for an Injective exchange-traded fund that would hold the token directly and allow staking, followed by a Canary product. It also said Gulf Labs joined the network as an institutional validator.
Separately, Coin Edition reported that CoinGecko attributed a 32.3% weekly gain to meetings between Injective's CEO and White House, SEC and CFTC officials, a staker vote on fixed gas fees, and the project's revenue to fully diluted value ratio. Coin Edition noted these were CoinGecko's explanations rather than confirmed causes.
The divergence between a handful of strong performers and the wider market underlines how selective buying has been this week. FXStreet said the broader market faced heightened volatility as hot wholesale and consumer inflation data pressured major tokens including $BTC.
Key takeaways Soros's Quantum Fund reportedly earned roughly $1 billion Britain abandoned its currency commitment on September 16, 1992 Emergency interest-rate increases failed to defend the
Key takeaways AI infrastructure spending creates new inflationary pressures worldwide Central bankers consider higher rates despite future productivity gains Data center investment intensifie